Exonate will be attending the European Association for Vision and Eye Research (EVER) 2017 Congress 27th - 30th September 2017.
Prof David Bates and our team will present an update on Exonate’s research into development of novel small molecule inhibitors of SRPK1 with improved scleral permeability properties for eye drop drug delivery. Exonate’s team are available for meetings whilst there and contact can be made via Louise Shave Louise.shave@exonate.com